Literature DB >> 7784537

Circadian distribution of motor activity and immobility in narcolepsy: assessment with continuous motor activity monitoring.

H A Middelkoop1, G J Lammers, B J Van Hilten, C Ruwhof, H Pijl, H A Kamphuisen.   

Abstract

The circadian distribution of motor activity and immobility of 14 unmedicated narcoleptics and matched controls was evaluated by monitoring continuous wrist motor activity 5 successive days and nights at home. Sleep was also assessed by sleep logs. The amplitude of the circadian rhythm of motor activity and immobility was significantly lower in narcoleptics than in controls. The variables that best distinguish narcoleptics from controls were the diurnal and nocturnal mean duration of uninterrupted immobility, which can be explained by excessive daytime sleepiness and frequent nocturnal awakenings, respectively. Thus, measures of diurnal and nocturnal motor activity and immobility appear useful for the objective assessment of some of the sleep-wakefulness manifestations of narcolepsy.

Entities:  

Mesh:

Year:  1995        PMID: 7784537     DOI: 10.1111/j.1469-8986.1995.tb02957.x

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  14 in total

1.  Actimetry in sleep medicine.

Authors:  O Kellner; H Bastuji; P Adeleine
Journal:  Sleep Breath       Date:  1997-03       Impact factor: 2.816

2.  Reward-seeking behavior in human narcolepsy.

Authors:  Alexandra Dimitrova; Rolf Fronczek; Janneke Van der Ploeg; Thomas Scammell; Shiva Gautam; Alvaro Pascual-Leone; Gert Jan Lammers
Journal:  J Clin Sleep Med       Date:  2011-06-15       Impact factor: 4.062

3.  Orexin modulates brown adipose tissue thermogenesis.

Authors:  Christopher J Madden; Domenico Tupone; Shaun F Morrison
Journal:  Biomol Concepts       Date:  2012-08

4.  Hypocretin-1 Levels Associate with Fragmented Sleep in Patients with Narcolepsy Type 1.

Authors:  Anniina Alakuijala; Tomi Sarkanen; Markku Partinen
Journal:  Sleep       Date:  2016-05-01       Impact factor: 5.849

5.  Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.

Authors:  Sawako Tabuchi; Tomomi Tsunematsu; Sarah W Black; Makoto Tominaga; Megumi Maruyama; Kazuyo Takagi; Yasuhiko Minokoshi; Takeshi Sakurai; Thomas S Kilduff; Akihiro Yamanaka
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

6.  Basal metabolic rate in narcoleptic patients.

Authors:  Norbert Dahmen; Peter Tonn; Leila Messroghli; David Ghezel-Ahmadi; Alice Engel
Journal:  Sleep       Date:  2009-07       Impact factor: 5.849

7.  Increased heart rate variability but normal resting metabolic rate in hypocretin/orexin-deficient human narcolepsy.

Authors:  Rolf Fronczek; Sebastiaan Overeem; Robert Reijntjes; Gert Jan Lammers; J Gert van Dijk; Hanno Pijl
Journal:  J Clin Sleep Med       Date:  2008-06-15       Impact factor: 4.062

8.  Impact of obesity in children with narcolepsy.

Authors:  Clara Odilia Inocente; Sophie Lavault; Michel Lecendreux; Yves Dauvilliers; Rubens Reimao; Marie-Paule Gustin; Sarah Castets; Karine Spiegel; Jian-Sheng Lin; Isabelle Arnulf; Patricia Franco
Journal:  CNS Neurosci Ther       Date:  2013-04-10       Impact factor: 5.243

9.  Gender differences between hypocretin/orexin knockout and wild type mice: age, body weight, body composition, metabolic markers, leptin and insulin resistance.

Authors:  Lalini Ramanathan; Jerome M Siegel
Journal:  J Neurochem       Date:  2014-08-21       Impact factor: 5.372

Review 10.  Brain orexin promotes obesity resistance.

Authors:  Catherine Kotz; Joshua Nixon; Tammy Butterick; Claudio Perez-Leighton; Jennifer Teske; Charles Billington
Journal:  Ann N Y Acad Sci       Date:  2012-07-17       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.